Brian Bell

The 340B Drug Pricing Program continues to face challenges and opportunities as we head into the fall. Read on for details on recent…

The HRSA’s annual 340B recertification window for hospitals will be open from August 14–September 11, 2023. Read on for more.

CMS has issued a proposed rule outlining the proposed remedy for the 340B-acquired drug payment policy for calendar years 2018–2022. Read…

All 340B covered entities that submit claims for separately payable Part B drugs and biologicals face a new requirement starting January 1,…

CMS has announced the final OPPS Rules for 2023, confirming that reimbursement payments for 340B drugs will be restored to ASP plus 6%.

The ruling on 340B reimbursement rate in the 2022 OPPS Rule may impact providers participating in APMs.